Gunpowder Capital Management, LLC dba Oliver Wealth Management »

Immunitybio shares owned by Gunpowder Capital Management, LLC dba Oliver Wealth Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Gunpowder Capital Management, LLC dba Oliver Wealth Management from 13F filings

Historical chart of Gunpowder Capital Management, LLC dba Oliver Wealth Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Gunpowder Capital Management, LLC dba Oliver Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Gunpowder Capital Management, LLC dba Oliver Wealth Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $28 15 1.93

More positions owned by Gunpowder Capital Management, LLC dba Oliver Wealth Management

Spdr Gold Shares Gold Shs (GLD)
Apple (AAPL)
Dimensional U.s. Core Equity 2 Etf Us Core Equity 2 (DFAC)
Dimensional Us Core Equity 1 Etf Us Core Equity 1 (DCOR)
Capital Group Divid Value Etf Shs Creation Unit Shs Creation Uni (CGDV)
Ishares Gold Tr Ishares Ishares New (IAU)
Spdr S&p 500 Etf Tr Unit (SPY)
Dimensional International Core Equity 2 Etf Intl Core Equity (DFIC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Incorporated Class A Cl A (META)
Palantir Technologies Incorporated Class A Cl A (PLTR)
Capital Group Growth Etf Shs Creation Unit Shs Creation Uni (CGGR)
Wal-Mart Stores (WMT)
Dimensional Emerging Markets Core Equity 2 Etf Emerging Mkts Co (DFEM)
Microsoft Corporation (MSFT)

View all positions for Gunpowder Capital Management, LLC dba Oliver Wealth Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Jane Street
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Woodline Partners
AlphaCore Capital
Two Sigma Investments
Charles Schwab Investment Management
Barclays
Tang Capital Management
Northern Trust
Citadel Advisors

View all funds holding Immunitybio